US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 0.7600
  • +0.0348+4.80%
Close Jul 11 16:00 ET
3.38MMarket Cap-554P/E (TTM)

Protagenic Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-346.22%-1.66M
-85.76%-3.7M
-532.51%-1.14M
-22.52%-655.77K
-80.83%-1.53M
13.64%-371.83K
28.76%-1.99M
55.33%-180.94K
50.23%-535.23K
-19.24%-847.08K
Net income from continuing operations
-140.12%-1.72M
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
Operating gains losses
-104.47%-198
1,268.74%630.32K
7,876.31%483.76K
96.66%23.18K
411.69%118.95K
-10.57%4.43K
156.72%46.05K
143.97%6.07K
--11.78K
--23.25K
Depreciation and amortization
13,868.89%12.57K
93,960.00%28.22K
88,626.67%26.62K
--1.42K
--91
--90
--30
--30
--0
--0
Other non cash items
----
-22.59%85.77K
22.72%31.24K
-82.50%4.45K
-24.30%25.18K
-6.49%24.9K
-74.06%110.8K
-47.89%25.45K
-74.72%25.46K
-85.13%33.26K
Change In working capital
-172.69%-109.13K
-121.18%-114.41K
-192.84%-176.58K
294.56%545.11K
-39.94%-633.07K
-77.40%150.13K
484.74%540.13K
-11.86%190.2K
126.09%138.15K
-314.30%-452.4K
-Change in prepaid assets
133.06%100.03K
-113.79%-87.09K
-189.48%-39.95K
1,626.13%770.6K
-545.61%-860.65K
-93.65%42.92K
231.47%631.73K
-60.75%44.64K
106.63%44.64K
-6.91%-133.31K
-Change in payables and accrued expense
-295.09%-209.16K
70.17%-27.33K
-193.86%-136.63K
-341.14%-225.49K
171.32%227.58K
1,026.72%107.21K
-126.93%-91.6K
42.63%145.56K
-34.97%93.51K
-2,158.54%-319.1K
Cash from discontinued investing activities
Operating cash flow
-346.22%-1.66M
-85.76%-3.7M
-532.51%-1.14M
-22.52%-655.77K
-80.83%-1.53M
13.64%-371.83K
28.76%-1.99M
55.33%-180.94K
50.23%-535.23K
-19.24%-847.08K
Investing cash flow
Cash flow from continuing investing activities
308.21%1.2M
199.03%4.78M
1,308.25%2.28M
65.22%590.72K
128.03%1.61M
-20.52%294.67K
116.12%1.6M
-66.71%161.77K
103.44%357.53K
706.92K
Net PPE purchase and sale
----
-8,197.78%-149.78K
-5,106.04%-93.97K
----
----
----
---1.81K
---1.81K
----
----
Net investment purchase and sale
308.21%1.2M
208.06%4.93M
1,350.16%2.37M
80.83%646.53K
128.03%1.61M
-20.52%294.67K
116.13%1.6M
-66.34%163.57K
103.44%357.53K
--706.92K
Cash from discontinued investing activities
Investing cash flow
308.21%1.2M
199.03%4.78M
1,308.25%2.28M
65.22%590.72K
128.03%1.61M
-20.52%294.67K
116.12%1.6M
-66.71%161.77K
103.44%357.53K
--706.92K
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
498.49%1.29M
-60.24%215.19K
-3.16%153.32K
-35.21%219.44K
-71.28%138.49K
-60.24%215.19K
-19.36%541.17K
-65.59%158.32K
-97.16%338.67K
151.56%482.18K
Current changes in cash
-491.34%-456.31K
370.06%1.07M
6,013.67%1.13M
63.39%-65.05K
157.27%80.27K
-29.03%-77.17K
-203.97%-396.84K
-123.71%-19.17K
98.45%-177.7K
-101.19%-140.16K
Effect of exchange rate changes
-59.31%190
-98.59%998
-98.79%920
59.83%-1.06K
120.06%671
-42.06%467
11,129.48%70.86K
38,109.05%76.04K
-40.67%-2.64K
-392.65%-3.35K
End cash Position
500.60%831.78K
498.49%1.29M
498.49%1.29M
-3.16%153.32K
-35.21%219.44K
-71.28%138.49K
-60.24%215.19K
-60.24%215.19K
-65.59%158.32K
-97.16%338.67K
Free cash flow
-346.22%-1.66M
-93.10%-3.85M
-577.68%-1.24M
-32.95%-711.57K
-80.83%-1.53M
13.64%-371.83K
28.69%-2M
54.89%-182.74K
50.23%-535.23K
-19.24%-847.08K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -346.22%-1.66M-85.76%-3.7M-532.51%-1.14M-22.52%-655.77K-80.83%-1.53M13.64%-371.83K28.76%-1.99M55.33%-180.94K50.23%-535.23K-19.24%-847.08K
Net income from continuing operations -140.12%-1.72M-40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K
Operating gains losses -104.47%-1981,268.74%630.32K7,876.31%483.76K96.66%23.18K411.69%118.95K-10.57%4.43K156.72%46.05K143.97%6.07K--11.78K--23.25K
Depreciation and amortization 13,868.89%12.57K93,960.00%28.22K88,626.67%26.62K--1.42K--91--90--30--30--0--0
Other non cash items -----22.59%85.77K22.72%31.24K-82.50%4.45K-24.30%25.18K-6.49%24.9K-74.06%110.8K-47.89%25.45K-74.72%25.46K-85.13%33.26K
Change In working capital -172.69%-109.13K-121.18%-114.41K-192.84%-176.58K294.56%545.11K-39.94%-633.07K-77.40%150.13K484.74%540.13K-11.86%190.2K126.09%138.15K-314.30%-452.4K
-Change in prepaid assets 133.06%100.03K-113.79%-87.09K-189.48%-39.95K1,626.13%770.6K-545.61%-860.65K-93.65%42.92K231.47%631.73K-60.75%44.64K106.63%44.64K-6.91%-133.31K
-Change in payables and accrued expense -295.09%-209.16K70.17%-27.33K-193.86%-136.63K-341.14%-225.49K171.32%227.58K1,026.72%107.21K-126.93%-91.6K42.63%145.56K-34.97%93.51K-2,158.54%-319.1K
Cash from discontinued investing activities
Operating cash flow -346.22%-1.66M-85.76%-3.7M-532.51%-1.14M-22.52%-655.77K-80.83%-1.53M13.64%-371.83K28.76%-1.99M55.33%-180.94K50.23%-535.23K-19.24%-847.08K
Investing cash flow
Cash flow from continuing investing activities 308.21%1.2M199.03%4.78M1,308.25%2.28M65.22%590.72K128.03%1.61M-20.52%294.67K116.12%1.6M-66.71%161.77K103.44%357.53K706.92K
Net PPE purchase and sale -----8,197.78%-149.78K-5,106.04%-93.97K---------------1.81K---1.81K--------
Net investment purchase and sale 308.21%1.2M208.06%4.93M1,350.16%2.37M80.83%646.53K128.03%1.61M-20.52%294.67K116.13%1.6M-66.34%163.57K103.44%357.53K--706.92K
Cash from discontinued investing activities
Investing cash flow 308.21%1.2M199.03%4.78M1,308.25%2.28M65.22%590.72K128.03%1.61M-20.52%294.67K116.12%1.6M-66.71%161.77K103.44%357.53K--706.92K
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position 498.49%1.29M-60.24%215.19K-3.16%153.32K-35.21%219.44K-71.28%138.49K-60.24%215.19K-19.36%541.17K-65.59%158.32K-97.16%338.67K151.56%482.18K
Current changes in cash -491.34%-456.31K370.06%1.07M6,013.67%1.13M63.39%-65.05K157.27%80.27K-29.03%-77.17K-203.97%-396.84K-123.71%-19.17K98.45%-177.7K-101.19%-140.16K
Effect of exchange rate changes -59.31%190-98.59%998-98.79%92059.83%-1.06K120.06%671-42.06%46711,129.48%70.86K38,109.05%76.04K-40.67%-2.64K-392.65%-3.35K
End cash Position 500.60%831.78K498.49%1.29M498.49%1.29M-3.16%153.32K-35.21%219.44K-71.28%138.49K-60.24%215.19K-60.24%215.19K-65.59%158.32K-97.16%338.67K
Free cash flow -346.22%-1.66M-93.10%-3.85M-577.68%-1.24M-32.95%-711.57K-80.83%-1.53M13.64%-371.83K28.69%-2M54.89%-182.74K50.23%-535.23K-19.24%-847.08K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg